We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Podium Session 4: Oncology - Prostate Monday, July 1, 2024 • 9:00-10:00.
- Abstract
The article compares 18F-Fluorine-18-labeled prostate-specific membrane antigen (PSMA)-1007 Positron emission tomography/computed tomography (PET/CT) with multiparametric MRI for locoregional staging of prostate cancer in a phase 2 trial. It highlights PSMA PET's superior accuracy in prostate cancer T stage, dominant nodules, laterality, and extracapsular extension compared to Magnetic Resonance Imaging (MRI), supporting use in preoperative assessments of intermediate- and high-risk tumors.
- Subjects
BRITISH Columbia; UROLOGY; PROSTATE tumors; MAGNETIC resonance imaging; CONFERENCES &; conventions
- Publication
Canadian Urological Association Journal, 2024, Vol 18, pS14
- ISSN
1911-6470
- Publication type
Article
- DOI
10.5489/cuaj.8823